title: [The optimal combination of ECT with pharmacotherapy].
abstract: The main indications for the electroconvulsive therapy (ECT) - psychotropic drug combination are pharmacotherapy-resistant, severe schizophrenic or affective psychoses. In such instances, a careful evaluation of the possible interactions between ECT and psychotropic drugs should precede the initiation of treatment in order to prevent adverse side effects. In this respect, the issues to be considered include the impact of concomittant pharmacotherapy on the seizure parameters of the ECT as well as the efficacy of the combined treatment relative to ECT or pharmacotherapy administered alone. This paper reviews the current literature on the use of benzodiazepines, mood stabilizers, antidepressants, antipsychotics together with ECT with the aim of providing recommendations for clinical practice.
authors.affiliation: Fövárosi önkormányzat Egyesített Szent István és Szent László Kórház-Rendelöintézet, Addiktológiai és Pszichiátriai Ambulancia, Budapest, Hungary. gazdag@lamb.hu
authors.forename: Gábor
authors.initials: G
authors.lastname: Gazdag
authors.forename: Rozália
authors.initials: R
authors.lastname: Takács
authors.forename: Gabor S
authors.initials: GS
authors.lastname: Ungvari
mesh_terms: D000339:Affect / Q000187:drug effects; D000928:Antidepressive Agents / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D004565:Electroconvulsive Therapy / Q000009:adverse effects; D006801:Humans; D000077213:Lamotrigine; D018020:Lithium Compounds / Q000627:therapeutic use; D019964:Mood Disorders / Q000188:drug therapy / Q000628:therapy*; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014227:Triazines / Q000627:therapeutic use; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D018692:Antimanic Agents; D002220:Carbamazepine; D000077213:Lamotrigine; D018020:Lithium Compounds; D017367:Selective Serotonin Reuptake Inhibitors; D014149:Tranquilizing Agents; D014227:Triazines; D014635:Valproic Acid